Companies: 10,795·Total market cap: $144.5T

F-star Therapeutics, Inc.

F-star Therapeutics, Inc.

FSTXNASDAQHealthcare

$7.12

+$0.00(+0.00%)

Market Cap$156511128

P/E Ratio—

52W High$7.12

52W Low$2.07

Avg Volume614K

Open$7.11

Beta-0.35

Net Income Financials Revenue

F-star Therapeutics, Inc. (FSTX) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

FSTX · net income · updated Jun 9, 2026

Core profitability metrics

FSTX · net income · margin · TTM · CAGR

Net income was −$31.3M for FY2021 (fiscal year ending 2021-12-31), down 22.1% year-over-year. Net profit margin was -147.8%.

FY2021 Net Income−$31.3M▼ -22.1% YoY

Trailing 12M (TTM)−$45.0Mtrailing 4 quarters sum

Net Profit Margin-147.8%−$31.3M ÷ $21.2M

YoY Change-22.1%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · FSTX net income history · FSTX profit margin

Annual net income data

FSTX · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2021Loss−$31.3M▼ 22.1%-147.8%$21.2M

FY2020Loss−$25.6M▼ 11.3%-227.6%$11.3M

FY2019Loss−$23.0M▼ 0.7%-81.3%$28.3M

FY2018Loss−$22.9M▲ +17.4%—$0

FY2017Loss−$27.7M▼ 59.4%—$0

Net income vs peers (Healthcare)

FSTX vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

F-star Therapeutics, Inc.YOU

FSTX

−$31.3M-22.1%-147.8%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

F-star Therapeutics, Inc. (FSTX) reported net income of −$31.3M for FY2021 (fiscal year ending 2021-12-31), down 22.1% year-over-year. The net profit margin was -147.8% — meaning the company kept $-1.48 of every dollar of revenue as profit.

F-star Therapeutics, Inc. has not yet achieved annual profitability based on available data (6 fiscal years). The company has reported net losses across all available periods.

F-star Therapeutics, Inc.'s net profit margin was -147.8% for FY2021, based on the latest annual results.

Investors sometimes search for "F-star Therapeutics, Inc. net worth" — the company's market capitalization is a separate figure from FSTX net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

FSTX net income · 4 questions

F-star Therapeutics, Inc. is not currently profitable on an annual basis. The company reported a net loss of $31.3M for FY2021.

is FSTX profitabledoes FSTX make a profitFSTX profitabilityFSTX profitable company

▸ Source: FMP /income-statement · GAAP · F-star Therapeutics, Inc. · F-star Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026